Emerging roles of cytosolic phosphoenolpyruvate kinase 1 (PCK1) in cancer.
Journal
Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
18
04
2023
revised:
20
07
2023
accepted:
09
08
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
Although it was traditionally believed that gluconeogenesis enzymes were absent from cancers that did not originate in gluconeogenic organs, numerous investigations have shown that they are functionally expressed in a variety of tumors as mediators of shortened forms of Gluconeogenesis. One of the isomers of PEPCK, the first-rate limiting enzyme in gluconeogenesis, is PCK 1, which catalyzes the conversion of oxaloacetate (OAA) and GTP into PEP, CO2, and GDP. It is also known as PEPCK-C or PCK1, and it is cytosolic. Despite being paradoxical, it has been demonstrated that, in addition to its enzymatic role in normal metabolism, this enzyme also plays a role in tumors that arise in gluconeogenic and non-gluconeogenic organs. According to newly available research, it has metabolic and non-metabolic roles in tumor progression and development. Thus, this review will give insight into
Identifiants
pubmed: 37637941
doi: 10.1016/j.bbrep.2023.101528
pii: S2405-5808(23)00109-7
pmc: PMC10457690
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
101528Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Cell Death Dis. 2017 Feb 23;8(2):e2626
pubmed: 28230855
Prog Lipid Res. 2020 Nov;80:101055
pubmed: 32791170
Mol Cell. 2018 Sep 6;71(5):718-732.e9
pubmed: 30193097
Cell. 2017 Oct 5;171(2):358-371.e9
pubmed: 28985563
Mol Genet Metab. 2022 Sep-Oct;137(1-2):18-25
pubmed: 35868242
Cell Death Dis. 2022 Aug 24;13(8):730
pubmed: 36002449
Cell Physiol Biochem. 2018;47(1):344-355
pubmed: 29768256
Nat Chem Biol. 2022 Dec;18(12):1380-1387
pubmed: 35970997
J Biol Chem. 1963 Jul;238:2259-63
pubmed: 13938894
Mol Med Rep. 2017 Dec;16(6):8563-8571
pubmed: 28990097
J Nucl Med. 2014 Nov;55(11):1766-71
pubmed: 25342384
Bioorg Med Chem Lett. 2007 Jul 15;17(14):3835-9
pubmed: 17532214
Cancer Lett. 2016 Nov 28;382(2):147-156
pubmed: 27609066
Curr Diab Rep. 2019 Sep 7;19(10):98
pubmed: 31494755
Hepatology. 2017 Aug;66(2):631-645
pubmed: 28387968
Mol Cell Endocrinol. 2011 Jan 1;331(1):102-8
pubmed: 20797423
Anticancer Drugs. 2022 Jan 1;33(1):e198-e206
pubmed: 34387592
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Reprod Biol Endocrinol. 2022 Mar 11;20(1):50
pubmed: 35277194
Cancer Res. 2015 Apr 1;75(7):1191-6
pubmed: 25712344
Cell Death Dis. 2017 Oct 5;8(10):e3068
pubmed: 28981119
J Exp Biol. 2019 Dec 12;222(Pt 24):
pubmed: 31767730
Int Rev Cell Mol Biol. 2017;332:213-231
pubmed: 28526133
J Inherit Metab Dis. 2022 Mar;45(2):223-234
pubmed: 34622459
Mol Oncol. 2020 Nov;14(11):2853-2867
pubmed: 32777161
Am J Physiol Endocrinol Metab. 2015 Jul 15;309(2):E105-14
pubmed: 26015436
Pediatr Clin North Am. 2018 Apr;65(2):247-265
pubmed: 29502912
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):24-36
pubmed: 31152822
Mol Cell. 2015 Nov 19;60(4):509-11
pubmed: 26590709
Curr Mol Med. 2019;19(4):247-272
pubmed: 30947672
J Hepatol. 2016 Feb;64(2):370-379
pubmed: 26462884
Nat Commun. 2019 Feb 7;10(1):623
pubmed: 30733434
J Clin Invest. 2021 Apr 15;131(8):
pubmed: 33690219
Cells. 2021 Jun 08;10(6):
pubmed: 34201101
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Drugs. 2021 Jun;81(8):923-933
pubmed: 33939118
Front Pharmacol. 2023 Feb 02;14:1097835
pubmed: 36817150
Nat Commun. 2013;4:2508
pubmed: 24149070
Int J Mol Sci. 2019 Jun 08;20(11):
pubmed: 31181727
J Dairy Sci. 2021 Jun;104(6):7252-7261
pubmed: 33741163
Biomed Pharmacother. 2020 Jan;121:109601
pubmed: 31739159
Funct Integr Genomics. 2023 Feb 25;23(1):67
pubmed: 36840800
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
Hum Mol Genet. 1993 Jan;2(1):1-4
pubmed: 8490617
FEMS Microbiol Lett. 2013 Feb;339(1):17-22
pubmed: 23136871
Oncoscience. 2015 Feb 17;2(2):151-86
pubmed: 25859558
Diabetes. 2015 Dec;64(12):3996-4010
pubmed: 26604176
J Inherit Metab Dis. 2021 Jul;44(4):792-808
pubmed: 33990986
Cancer Lett. 2017 Jun 1;395:63-71
pubmed: 28259820
J Exp Clin Cancer Res. 2019 Feb 4;38(1):50
pubmed: 30717766
J Biol Chem. 2012 Oct 26;287(44):37098-108
pubmed: 22977252
J Lipid Res. 2010 Jun;51(6):1452-63
pubmed: 20124556
Aging (Albany NY). 2022 Apr 11;14(7):3233-3258
pubmed: 35404841
J Inherit Metab Dis. 2015 Sep;38(5):881-7
pubmed: 25601412
Cancer Metab. 2019 Aug 01;7:8
pubmed: 31388420
Oncol Rep. 2016 Dec;36(6):3131-3138
pubmed: 27748938
Elife. 2019 Dec 16;8:
pubmed: 31841108
Diabetes. 2012 Feb;61(2):513-23
pubmed: 22210316
Chin Med J (Engl). 2020 Jul 20;133(14):1688-1695
pubmed: 32604177
Cancer Res. 2020 Mar 1;80(5):1143-1155
pubmed: 31932456
Aging Dis. 2022 Apr 1;13(2):521-533
pubmed: 35371601
J Biol Chem. 2014 Mar 14;289(11):7257-63
pubmed: 24497630
Mol Genet Metab. 2016 May;118(1):21-7
pubmed: 26971250
J Biol Chem. 1985 Sep 5;260(19):10748-60
pubmed: 2993287
Onco Targets Ther. 2020 Mar 30;13:2613-2627
pubmed: 32280238
Mol Cancer. 2013 Sep 25;12(1):110
pubmed: 24063558
Cancer Res. 2016 Jun 1;76(11):3265-76
pubmed: 27197151
Mol Cancer Res. 2014 Nov;12(11):1547-59
pubmed: 25001192
Br J Cancer. 2022 Mar;126(5):778-790
pubmed: 34815524
Nat Rev Cancer. 2016 Oct;16(10):650-62
pubmed: 27634448
Nat Metab. 2020 Feb;2(2):127-129
pubmed: 32694689
Cytokine Growth Factor Rev. 2015 Oct;26(5):533-44
pubmed: 26187859
Mol Cell Biol. 2013 Aug;33(15):2891-902
pubmed: 23716591
Orphanet J Rare Dis. 2011 May 20;6:27
pubmed: 21599942
Science. 2015 Jul 10;349(6244):187-91
pubmed: 26160948
Trends Cancer. 2019 Jan;5(1):30-45
pubmed: 30616754
Nat Rev Endocrinol. 2017 Dec;13(12):710-730
pubmed: 28849786
J Physiol. 2021 Mar;599(6):1745-1757
pubmed: 33347611
Biochimie. 2010 Dec;92(12):1772-7
pubmed: 20691246
Genes Dis. 2022 Mar 22;10(1):101-112
pubmed: 37013052
BMC Cancer. 2014 Mar 06;14:160
pubmed: 24602180
Cancers (Basel). 2022 Oct 05;14(19):
pubmed: 36230802
Mol Cell. 2015 Nov 19;60(4):571-83
pubmed: 26481663
Front Oncol. 2018 Dec 17;8:611
pubmed: 30619751
Sci Rep. 2019 Apr 16;9(1):6161
pubmed: 30992462
Oncotarget. 2018 May 25;9(40):26259-26278
pubmed: 29899857
Front Endocrinol (Lausanne). 2019 Jan 24;9:802
pubmed: 30733709
Nat Commun. 2017 Feb 27;8:14420
pubmed: 28240261
Cell Metab. 2015 Oct 6;22(4):669-81
pubmed: 26344103
Biochem Biophys Res Commun. 2018 Apr 15;498(4):925-931
pubmed: 29545180
Mol Cell. 2011 Jul 8;43(1):33-44
pubmed: 21726808
Curr Pharm Des. 2014;20(15):2619-26
pubmed: 23859617
Sci Rep. 2020 Dec 17;10(1):22177
pubmed: 33335245
Oncogene. 2018 Mar;37(12):1637-1653
pubmed: 29335519
J Biol Chem. 2019 Dec 13;294(50):19269-19278
pubmed: 31662435
Cold Spring Harb Symp Quant Biol. 2011;76:285-9
pubmed: 22096030
Lab Invest. 2019 Mar;99(3):305-318
pubmed: 29884909
Cell Death Dis. 2015 Sep 03;6:e1872
pubmed: 26335714
Nature. 2020 Apr;580(7804):530-535
pubmed: 32322062
Mol Genet Metab. 2017 Apr;120(4):337-341
pubmed: 28216384
J Biol Chem. 2021 Jan-Jun;296:100205
pubmed: 33334880
Oxid Med Cell Longev. 2022 May 6;2022:6766787
pubmed: 35571245
Comp Biochem Physiol B Biochem Mol Biol. 2017 Sep;211:1-7
pubmed: 28254380
Eur J Cancer. 2021 Jan;142:123-131
pubmed: 33278777
Cell Rep. 2016 Oct 11;17(3):821-836
pubmed: 27732857
Cancer Res. 2018 Feb 15;78(4):909-921
pubmed: 29269518
Zhonghua Gan Zang Bing Za Zhi. 2022 Feb 20;30(2):213-219
pubmed: 35359074
Genes Dis. 2019 Apr 16;7(1):150-159
pubmed: 32181286
Cancer Commun (Lond). 2020 Sep;40(9):389-394
pubmed: 32809272
Mol Metab. 2021 Nov;53:101257
pubmed: 34020084